Miller Andrew Craig bought KYTX
February 24, 2026 · Form 4 insider transaction
Miller Andrew Craig bought 42,945 shares of Kyverna Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 8 days after the transaction.
Direction
Acquired (buy-side)
Shares
42,945
Price
$0.00
Total value
N/A
InsiderMiller Andrew Craig
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 24, 2026
Filing dateMarch 4, 2026
Shares owned after42,945
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/36th of the shares subject to the option shall vest on each monthly anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.